Payment overview · 2025
General Payments
$68.54
1 reported records · 1 companies
Healthcare provider profile · identity verified
Alice C Bustos, MD
Allopathic & Osteopathic Physicians|Family Medicine · WEST ALLIS, WI · NPI 1861440505
Verified facts
What the public records show
CMS Open Payments records show Alice C Bustos, MD received $68.54 in general payments during 2025 across 1 reported records.
Novartis Pharmaceuticals Corporation accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $68.54 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $68.54 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 868 | 239 |
| Amlodipine Besylate | Amlodipine Besylate | 632 | 169 |
| Gabapentin | Gabapentin | 350 | 74 |
| Pantoprazole Sodium | Pantoprazole Sodium | 277 | 69 |
| Levothyroxine Sodium | Levothyroxine Sodium | 264 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 261 | 75 |
| Losartan Potassium | Losartan Potassium | 257 | 63 |
| Hydrochlorothiazide | Hydrochlorothiazide | 246 | 68 |
| Metformin Hcl | Metformin Hcl | 244 | 63 |
| Metformin Hcl Er | Metformin Hcl | 235 | 70 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 215 | 64 |
| Omeprazole | Omeprazole | 194 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 183 | 55 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 164 | 66 |
| Ezetimibe | Ezetimibe | 142 | 38 |
| Furosemide | Furosemide | 141 | 46 |
| Lisinopril | Lisinopril | 141 | 42 |
| Jardiance | Empagliflozin | 139 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 133 | 35 |
| Mirtazapine | Mirtazapine | 123 | 36 |
| Potassium Chloride | Potassium Chloride | 119 | 34 |
| Enalapril Maleate | Enalapril Maleate | 116 | 31 |
| Montelukast Sodium | Montelukast Sodium | 116 | 28 |
| Metoprolol Tartrate | Metoprolol Tartrate | 104 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 102 | 25 |
| Tizanidine Hcl | Tizanidine Hcl | 101 | 38 |
| Allopurinol | Allopurinol | 97 | 28 |
| Symbicort | Budesonide/Formoterol Fumarate | 97 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 89 | 19 |
| Sertraline Hcl | Sertraline Hcl | 89 | 21 |
| Simvastatin | Simvastatin | 89 | 26 |
| Eliquis | Apixaban | 87 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 83 | 25 |
| Valsartan | Valsartan | 83 | 26 |
| Mounjaro | Tirzepatide | 82 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 78 | 16 |
| Trazodone Hcl | Trazodone Hcl | 75 | 16 |
| Bupropion Xl | Bupropion Hcl | 74 | 17 |
| Januvia | Sitagliptin Phosphate | 74 | 15 |
| Pregabalin | Pregabalin | 67 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 63 | 19 |
| Carvedilol | Carvedilol | 60 | 18 |
| Ozempic | Semaglutide | 60 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 54 | 16 |
| Glimepiride | Glimepiride | 52 | 13 |
| Alendronate Sodium | Alendronate Sodium | 51 | 19 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 41 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 41 | suppressed |
| Celecoxib | Celecoxib | 39 | suppressed |
| Famotidine | Famotidine | 38 | 12 |
| Tramadol Hcl | Tramadol Hcl | 38 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 36 | suppressed |
| Lovastatin | Lovastatin | 36 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 35 | suppressed |
| Atenolol | Atenolol | 34 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 34 | suppressed |
| Baclofen | Baclofen | 33 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 31 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 31 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 31 | suppressed |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | 14 |
| Lidocaine | Lidocaine | 28 | suppressed |
| Meloxicam | Meloxicam | 28 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | 11 |
| Arnuity Ellipta | Fluticasone Furoate | 25 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 25 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 25 | 23 |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Tamsulosin Hcl | Tamsulosin Hcl | 24 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 23 | 21 |
| Torsemide | Torsemide | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Telmisartan | Telmisartan | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 20 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 19 | suppressed |
| Levetiracetam | Levetiracetam | 19 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Ondansetron Odt | Ondansetron | 18 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Prednisone | Prednisone | 17 | suppressed |
| Trulicity | Dulaglutide | 17 | suppressed |
| Acamprosate Calcium | Acamprosate Calcium | 16 | suppressed |
| Azithromycin | Azithromycin | 16 | 16 |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Clotrimazole | Clotrimazole | 16 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Varenicline Tartrate | Varenicline Tartrate | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 14 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Amlodipine-Atorvastatin | Amlodipine/Atorvastatin | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | 12 |
| Estradiol | Estradiol | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 12 | 12 |
| Rybelsus | Semaglutide | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Azathioprine | Azathioprine | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 11 | suppressed |
| Verapamil Sr | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $68.54 · 1 records | Novartis Pharmaceuticals Corporation | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error